Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Dec 22, 2023
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder of eRA Commons ID Requirement for All Personnel on the R&R Senior/Key Person Profile Form
(NOT-OD-24-042)
National Institutes of Health
Agency for Healthcare Research and Quality
Food and Drug Administration
- Reminder: NIH Natural Disaster and Other Emergencies Flexibilities
(NOT-OD-24-043)
National Institutes of Health
- Reminder for NIH Closeout Reporting Requirements and Closeout Email Notifications
(NOT-OD-24-047)
National Institutes of Health
- Notice to Extend the Expiration Date for PA-20-272 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
(NOT-OD-24-048)
National Institutes of Health
General Notices
- Updated NIAAA Data and Safety Monitoring Plan Guidelines for NIAAA-Supported Clinical Trials
(NOT-AA-24-003)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Need to Expire and Reissue PAR-23-256 Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
(NOT-AT-24-026)
National Center for Complementary and Integrative Health
- Notice of NCIs Participation in NIH Mentored Research Scientist Development Awards (Parent K01) Notices of Funding Opportunity
(NOT-CA-24-020)
National Cancer Institute
- Notice of Change in Funding Opportunity Expiration Date and Eligible Organizations for "Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)" (PAR-24-038)
(NOT-DE-24-007)
National Institute of Dental and Craniofacial Research
- Notice of a Question and Answer "Office Hour" with NIGMS Staff for PAR-22-220, Postbaccalaureate Research Education Program (PREP)
(NOT-GM-24-023)
National Institute of General Medical Sciences
- Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009)
(NOT-HL-23-125)
National Heart, Lung, and Blood Institute
- Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function
(NOT-MH-24-140)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Notice of Information for Development for Advancing the Careers of a Diverse Research Workforce in Translational Neuroscience
(NOT-NS-23-111)
National Institute of Neurological Disorders and Stroke
- Notice of Pre-Application Webinar and FAQs for the Multi-Sectoral Preventive Interventions (MSPI) Research Network: PAR-24-053 (UG3/UH3, Clinical Trial Required) and RFA-OD-24-006 (U24, Clinical Trial Not Allowed)
(NOT-OD-24-050)
Office of Disease Prevention
- The BIO-Entrepreneurship Capstone
(NOT-OD-24-051)
Office of the Director, NIH
- Request for Information (RFI): Current Capabilities in Automated Data Entry & Extraction from Electronic Health Records
(NOT-CA-24-021)
National Cancer Institute
- Request for Information (RFI): Inviting Input on an NIH-Wide Strategic Plan for Autoimmune Disease Research
(NOT-OD-24-049)
Office of Research on Women's Health
Notice of Changes to Funding Opportunities
- Notice to Extend the Response Date for NOT-AR-23-022 "Request for Information on Themes for the NIAMS Strategic Plan for Fiscal Years 2025-2029"
(NOT-AR-23-024)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Change to Eligibility Information for RFA-DA-24-026, "NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)"
(NOT-DA-23-048)
National Institute on Drug Abuse
- Notice of Participation of NIDCD in NOT-OD-24-032 "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"
(NOT-DC-24-014)
National Institute on Deafness and Other Communication Disorders
- Notice of Clarification and Change to Budget Limits for PAR-23-114, "Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)"
(NOT-EB-23-024)
National Institute of Biomedical Imaging and Bioengineering
- Clarification of Data Management and Sharing Plan Instructions in PAR-23-100 "IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)"
(NOT-GM-24-022)
National Institute of General Medical Sciences
- Notice of Participation of NIMHD in NOT-OD-24-032, "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-MD-24-003)
National Institute on Minority Health and Health Disparities
- Notice of Change to Allow Post-Submission Materials for RFA-NS-24-028 and RFA-NS-22-049
(NOT-NS-24-046)
National Institute of Neurological Disorders and Stroke
- Notice of Change to Funding Opportunity: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
(NOT-TW-24-002)
John E. Fogarty International Center
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
(NOT-DK-24-004)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Intent to Publish a Funding Opportunity Announcement for Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)
(NOT-DK-24-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Requests for Proposal
- NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Anti-Aging Activity in Mice
(NOT-AG-23-077)
National Institute on Aging
- 2024 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2024-1 Now Available
(NOT-AI-24-014)
National Institute of Allergy and Infectious Diseases
- Intramural Loan Repayment Program for AIDS Research (AIDS-LRP)
(NOT-OD-24-033)
Office of the Director, NIH
- Intramural Loan Repayment Program for Clinical Researchers from Disadvantaged Backgrounds (CR-LRP)
(NOT-OD-24-034)
Office of the Director, NIH
- Intramural Loan Repayment Program for General Research (GR-LRP)
(NOT-OD-24-035)
Office of the Director, NIH
- Intramural Loan Repayment Program for General Research for ACGME Fellows (ACGME-LRP)
(NOT-OD-24-036)
Office of the Director, NIH
Notices of Special Interest
- Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
(NOT-CA-24-022)
National Cancer Institute
- Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
(NOT-CA-24-023)
National Cancer Institute
- Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases
(NOT-DK-24-007)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for Select NIGMS-Funded Awards
(NOT-GM-24-021)
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
(NOT-HG-24-012)
National Human Genome Research Institute
- Notice of Special Interest (NOSI): Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia
(NOT-MH-24-130)
National Institute of Mental Health
Funding Opportunities
- Geroscience Course (R25 Independent Clinical Trial Not Allowed)
(PAR-23-315)
National Institute on Aging
Office of Dietary Supplements - NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
(PAR-24-074)
National Institute of Diabetes and Digestive and Kidney Diseases - Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
(PAR-24-075)
Office of the Director, NIH
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
(PAR-24-076)
Office of the Director, NIH
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Nursing Research - Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
(PAR-24-080)
National Institute of Allergy and Infectious Diseases - NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
(PAR-24-083)
National Center for Complementary and Integrative Health - Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
(PAR-24-084)
National Center for Complementary and Integrative Health - Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
(PAR-24-086)
National Center for Complementary and Integrative Health - Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
(PAR-24-087)
National Center for Complementary and Integrative Health - Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-24-090)
National Center for Complementary and Integrative Health - High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)
(RFA-AA-24-001)
National Institute on Alcohol Abuse and Alcoholism - High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed)
(RFA-AA-24-002)
National Institute on Alcohol Abuse and Alcoholism - Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed)
(RFA-AI-24-002)
National Institute of Allergy and Infectious Diseases - Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
(RFA-DA-25-007)
National Institute on Drug Abuse - Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)
(RFA-DA-25-008)
National Institute on Drug Abuse - Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders (UG3/UH3 Clinical Trial Optional)
(RFA-DA-25-028)
National Institute on Drug Abuse - NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
(RFA-DC-24-007)
National Institute on Deafness and Other Communication Disorders
Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed
(RFA-FD-24-015)
Food and Drug Administration- Produce Safety Alliance-U01 Clinical Trials Not Allowed
(RFA-FD-24-018)
Food and Drug Administration - Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Clinical Trials Not Allowed
(RFA-FD-24-020)
Food and Drug Administration - Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
(RFA-FD-24-025)
Food and Drug Administration - Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed
(RFA-FD-24-026)
Food and Drug Administration - Critical Path Public Private Partnerships Clinical Trials Optional
(RFA-FD-24-027)
Food and Drug Administration - Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Optional)
(RFA-NR-24-003)
National Institute of Nursing Research
Office of Disease Prevention
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.